Impaired autophagy in Lafora disease
Por:
E. KNECHT, C. AGUADO, S. SARKAR, V. KOROLCHUK, O. CRIADO-GARCIA, S. VERNIA, P. BOYA, P. SANZ, S. DE CORDOBA and D. RUBINSZTEIN
Publicada:
1 oct 2010
Resumen:
Lafora disease (LD) is a progressive, lethal, autosomal recessive, neurodegenerative disorder that manifests with myoclonus epilepsy. LD is characterized by the presence of intracellular inclusion bodies called Lafora bodies (LB), in brain, spinal cord and other tissues. More than 50 percent of LD is caused by mutations in EPM2A that encodes laforin. Here we review our recent findings that revealed that laforin regulates autophagy. We consider how autophagy compromise may predispose to LB formation and neurodegeneration in LD, and discuss future investigations suggested by our data.
Filiaciones:
:
Cell Biol Lab, Valencia, Spain
Ctr Invest Principe Felipe, Valencia, Spain
CIBERER, Valencia, Spain
:
Cell Biol Lab, Valencia, Spain
Ctr Invest Principe Felipe, Valencia, Spain
CIBERER, Valencia, Spain
S. SARKAR:
Dept Med Genet, Cambridge, England
Addenbrookes Hosp, Inst Med Res, Cambridge, England
V. KOROLCHUK:
Dept Med Genet, Cambridge, England
Addenbrookes Hosp, Inst Med Res, Cambridge, England
O. CRIADO-GARCIA:
CSIC, Ctr Invest Biol, Madrid, Spain
CIBERER, Madrid, Spain
S. VERNIA:
CIBERER, Valencia, Spain
CSIC, Inst Biomed Valencia, Valencia, Spain
P. BOYA:
CSIC, Ctr Invest Biol, Madrid, Spain
CIBERER, Madrid, Spain
P. SANZ:
CIBERER, Valencia, Spain
CSIC, Inst Biomed Valencia, Valencia, Spain
S. DE CORDOBA:
CSIC, Ctr Invest Biol, Madrid, Spain
CIBERER, Madrid, Spain
D. RUBINSZTEIN:
Dept Med Genet, Cambridge, England
Addenbrookes Hosp, Inst Med Res, Cambridge, England
|